NFKB1 and breast cancer: Specifically, NF-κB p65 directly binds to the promoter region of NAT10 to activate its transcription, which in turn enhances DNA damage repair by protecting neuroblast differentiation-associated protein mRNA from exonuclease degradation, thereby increasing cisplatin resistance in BC cells.